Copyright 2020 The Science Publishers
All Rights Reserved for Website Design.
>    Suggest a new journal           

>   Manuscript editing services           

>   Ethical guidelines         

>   Terms and conditions
>    Home           

>   Jounals 

>   Join us       

>   Contact us

Home        About Us        Journals        Join Us        Services        Contact Us           




advanced
ISSN 2410-955X - An International Biannual Journal
BIOMEDICAL LETTERS
Molecular docking studies elucidate potential hydroxyproline dehydrogenase compounds for schizophrenia inhibition
Syed Atta-ul-Mubeen Shah 1,*, Jonathan Javid 1, Haseeb Akram 2

1 Department of Bioinformatics and Biotechnology, Government College University Faisalabad, Pakistan
2 District Head Quarter Hospital, Chiniot, Pakistan

Abstract
Hydroxyl Proline dehydrogenase HYPDH is an enzyme used in the dehydrogenation of proline and is involved in the conversion of trans-4hydroxy proline to ?-1- pyrroline-3-hydroxy-5-carboxylate oxidized to glutamate. PRODH2 is involved schizophrenia through microdeletion results in the loss of gene sequence. Consequently, the production of glutamate effected lead to a neurodegenerative disorder called schizophrenia which affects 1% of the population and is characterized by several behavioral abnormalities and lack of social behavior. Bioinformatics techniques were used for the prediction of 3D structures and protein-protein molecular docking studies of PRODH2. Threading and homology modeling approaches were employed for 3D structure prediction of PRODH2. STRING database was used and ALDH4A1 was observed as the interacting partner of PRODH2. Protein-protein docking studies of PRODH2 against ALDH4A1 were done to analyze the interacting potential residues. Virtual screening was performed against FDA library from ZINC database and molecular docking was done by AutoDock Vina. It was observed that ZINC000016 molecule has least binding energy of -12.2 kcal/mol. The scrutinized compound may have potential for further drug discovery processes. The observed results of this research may help in designing the novel therapeutic targets against PRODH2.

A R T I C L E  I N F O

Received
March 21, 2020
Revised
May 03, 2020
Accepted
June 17, 2020

*Corresponding Author
Syed Atta-ul-Mubeen Shah
E-mail
syedattaulmubeenshah@gmail.com

Keywords
Schizophrenia
Structure prediction
Molecular docking
PRODH2
Virtual screening
Computer-aided drug designing


Research article


2020 | Volume 6 | Issue 2: Special issue articles: Computational drug designing and molecular docking analyses